profound interest in human behavior and emotions and strong urge to ease children’s suffering. In the next five years we plan to study the genetic basis of autism and the pharmacogenetic profiles of epilepsy drugs. We are building a world-class patient sample biobank for childhood neuropsychiatric disorders, including case-control samples, multiplex families and twins.